This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Applying this photoenzymatic approach, researchers have developed a clean, efficient way to synthesize crucial chemical building blocks known as chiral amines, solving a longstanding challenge in syntheticchemistry.
On September 15th, Strateos hosted Part 2 of its Chemistry Webinar Series: Remote Access Robotic Controlled Compound Synthesis. It’s really a shift towards industrializing how we do science.” Ben Miles, Ph.D., “Automation and software-controlled experimentation drives reproducibility at a click of a button.
My journey in the field of science has been highly enriching and gratifying. So, somehow, I ended up in science and once I started, there was no looking back. At USP India, Dr Jaywant oversees the Compendial Development, the SyntheticChemistry, and the Analytical Research and Development Laboratories.
Working closely with AWS experts in machine learning and analytics, we aim to provide our scientists and researchers with the insights they need to help deliver medical breakthroughs that change patients’ lives,” said Andrew McKillop, Vice President of Pharmaceutical Sciences, Worldwide Research, Development, and Medical at Pfizer.
Kazumi holds a PhD in SyntheticChemistry from UC Berkeley. She holds a PhD from the University of Illinois at Urbana-Champaign, and a Bachelor of Science from Iowa State University. She is also a Board member of the Sandford Burnham Prebys Institute.
The focus of this year’s SLAS 2022 was to accelerate life sciences research through the adoption and integration of transformative lab automation technologies. The consensus among the panel is that life science research is evolving from a process-driven approach to a data-driven one. Here are some highlights from SLAS 2022.
That’s how we’ll get the greatest leverage from our science and turn it into as many medicines as possible. Our Chinese CROs are back online and doing syntheticchemistry at a pre-pandemic pace. Our relationship with Roche gives us the ability to focus on our science and delivering the first rSMs to patients. We’re lucky.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content